Tanaka Capital Management Inc Ionis Pharmaceuticals Inc Transaction History

Tanaka Capital Management Inc

$43.2 Million
Q3 2024

A detailed history of Tanaka Capital Management Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Tanaka Capital Management Inc holds 14,512 shares of IONS stock, worth $530,123. This represents 1.34% of its overall portfolio holdings.

Number of Shares

14,512

Previous 14,512 -0.0%

Holding current value

$530,123

Previous $692,000 16.04%

% of portfolio

1.34%

Previous 1.64%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$36.45 - $47.7 $3,645 - $4,770	-100 Reduced 0.68%	14,512 $692,000
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $288,750 - $353,475	7,500 Added 105.46%	14,612 $663,000
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $45,503 - $61,705	-1,435 Reduced 16.79%	7,112 $263,000
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $9,412 - $11,667	-315 Reduced 3.55%	8,547 $317,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $199,732 - $273,744	-7,799 Reduced 46.81%	8,862 $270,000
Q2 2021 Aug 13, 2021	SELL	$34.54 - $47.25 $136,433 - $186,637	-3,950 Reduced 19.16%	16,661 $665,000
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $161,750 - $242,682	3,805 Added 22.64%	20,611 $927,000
Q4 2020 Feb 11, 2021	SELL	$45.3 - $60.27 $77,689 - $103,363	-1,715 Reduced 9.26%	16,806 $950,000
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $47,829 - $63,453	-1,008 Reduced 5.16%	18,521 $879,000
Q2 2020 Aug 17, 2020	SELL	$46.85 - $61.05 $23,940 - $31,196	-511 Reduced 2.55%	19,529 $1.15 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $418,787 - $638,247	-10,067 Reduced 33.44%	20,040 $947,000
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $30,694 - $37,203	-570 Reduced 1.86%	30,107 $1.82 Million
Q3 2019 Nov 15, 2019	SELL	$59.06 - $72.15 $117,706 - $143,794	-1,993 Reduced 6.1%	30,677 $1.84 Million
Q2 2019 Aug 15, 2019	SELL	$62.09 - $86.14 $106,856 - $148,246	-1,721 Reduced 5.0%	32,670 $2.1 Million
Q1 2019 May 16, 2019	SELL	$52.92 - $81.17 $109,491 - $167,940	-2,069 Reduced 5.67%	34,391 $2.79 Million
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $11,926 - $16,373	-275 Reduced 0.75%	36,460 $1.97 Million
Q2 2018 Aug 16, 2018	SELL	$40.53 - $50.7 $547,762 - $685,210	-13,515 Reduced 26.9%	36,735 $1.53 Million
Q1 2018 May 15, 2018	SELL	$44.08 - $55.05 $98,342 - $122,816	-2,231 Reduced 4.25%	50,250 $2.22 Million
Q4 2017 Feb 16, 2018	SELL	$50.3 - $64.39 $483,886 - $619,431	-9,620 Reduced 15.49%	52,481 $2.64 Million
Q3 2017 Nov 16, 2017	BUY	$45.56 - $59.57 $2.83 Million - $3.7 Million	62,101	62,101 $3.15 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tanaka Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tanaka Capital Management Inc with notifications on news.

Account

Tanaka Capital Management Inc Ionis Pharmaceuticals Inc Transaction History